Factors Influencing the Induction Phase of Skin Sensitization

American Journal of Contact Dermatitis

Volumn 14, Issue 4, 2003, Pages 188-194

  Dearman, Rebecca J ^a   Kimber, Ian ^a  

^a JEALOTT S HILL INTERNATIONAL RESEARCH CENTRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; CYTOKINE;

ANTIGEN PRESENTING CELL; CYTOKINE PRODUCTION; EPIDERMIS; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; PRIORITY JOURNAL; REVIEW; SKIN ALLERGY; SKIN CELL; SKIN PENETRATION; SKIN SENSITIZATION; T LYMPHOCYTE; TOXICITY TESTING;

EID: 0347916953     PISSN: 1046199X     EISSN: None     Source Type: Report    
DOI: 10.1097/01634989-200312000-00003     Document Type: Review

References (64)

1. Kimber I, Basketter DA, Gerberick GF, et al. Allergic contact dermatitis. Int Immunopharmacol 2002;2:201-11.
2. Rustemeyer T, Van Hoogstraten IMW, Von Blomberg BME, et al. Mechanisms in allergic contact dermatitis. In: Rycroft RJG, Menne T, Frosch PJ, Lepoittevin J-P, editors. Textbook of contact dermatitis. 3rd ed. Berlin: Springer; 2001. p. 14-58.
3. Smith CK, Hotchkiss SAM. Allergic contact dermatitis. Chemical and metabolic mechanisms. London: Taylor & Francis; 2001.
4. Albanesi C, Cavani A, Girolomoni G. IL-17 is produced by nickel-specific T lymphocytes and regulates ICAM-1 expression and chemokine production in human keratinocytes: synergistic or antagonistic effects with IFN-γ and TNF-α. J Immunol 1999;162:494-502.
5. McHale JF, Harari OA, Marshall D, et al. Vascular endothelial cell expression of ICAM-1 and VCAM-1 at the onset of eliciting contact hypersensitivity in mice: evidence for a dominant role of TNF-α. J Immunol 1999;162:1648-55.
6. Sebastiani S, Albanesi C, De Pita O, et al. The role of chemokines in allergic contact dermatitis. Arch Dermatol Res 2002;293:552-9.
7. Grabbe S, Schwarz T. Immunoregulatory mechanisms involved in elicitation of allergic contact hypersensitivity. Immunol Today 1998;19:37-44.
8. Kimber I, Dearman RJ, Cumberbatch M, et al. Langerhans cells and chemical allergy. Curr Opin Immunol 1998;10:614-9.
9. Kimber I, Cumberbatch M, Dearman RJ, et al. Cytokines and chemokines in the initiation and regulation of epidermal Langerhans cell mobilization. Br J Dermatol. 2000;142:401-12.
10. Flynn GL. Physicochemical determinants of skin absorption. In: Gerity TR, Henry CJ, editors. Principles of route-to-route-extrapolation for risk assessment. New York: Elsevier; 1990. p. 93-127.
11. Bodin A, Shao LP, Nilsson JLG, et al. Identification and allergenic activity of hydroxyaldehydes-a new type of oxidation product from an ethoxylated non-ionic surfactant. Contact Dermatitis 2001;44:207-12.
12. Ashby J, Hilton J, Dearman RJ, et al. Mechanistic relationship among mutagenicity, skin sensitization and skin carcinogenicity. Environ Health Perspect 1993;10:62-7.
13. Ashby J, Hilton J, Dearman RJ, et al. Streptozotocin: inherent but not expressed skin sensitising activity. Contact Dermatitis 1995;33:165-7.
14. Bos JD, Meinardi MMHM. The 500 Dalton rule for skin penetration of chemical compounds and drugs. Exp Dermatol 2000;9:165-9.
15. Landsteiner K, Jacobs J. Studies on the sensitization of animals with simple chemical compounds. J Exp Med 1936;64:625-39.
16. Dupuis G, Benezra C. Allergic contact dermatitis to simple chemicals. New York: Marcel Dekker; 1982.
17. Roberts DW, Lepoittevin J-P. Hapten-protein interactions. In: Lepoittevin J-P, Basketter DA, Goossens A, Karlberg A-T, editors. Allergic contact dermatitis: the molecular basis. Berlin: Springer-Verlag; 1998. p. 81-111.
18. Ashby J, Basketter DA, Paton D, et al. Structure-activity relationships in skin sensitization using the murine local lymph node assay. Toxicology 1995;103:177-94.
19. Sadhra S, Foulds IS, Gray CN. Oxidation of resin acids in colophony (rosin) and its implications for patch testing. Contact Dermatitis 1998;39:58-63.
20. Karlberg AT, Boman A, Melin B. Animal experiments on the allergenicity of d-limonene-the citrus solvent. Ann Occup Hyg 1991;35:419-26.
21. Cheung C, Hotchkiss SA, Pease CK. Cinnamic compound metabolism in human skin and the role metabolism may play in determining relative sensitisation potency. J Dermatol Sci 2003;31:9-19.
22. Elahi EN, Wright Z, Hotchkiss SAM, et al. Protein binding and metabolic inhibition reveals clues on the mechanisms surrounding relative potency of sensitising cinnamic compounds. Toxicology 2002;178:43-4.
23. Shornick LP, De Togni P, Mariathasan S, et al. Mice deficient in IL-1beta manifest impaired contact hypersensitivity to trinitrochlorobenzene. J Exp Med 1996;183:1427-36.
24. Antonopoulos C, Cumberbatch M, Dearman RJ, et al. Functional caspase-1 is required for Langerhans cell migration and optimal contact sensitization in mice. J Immunol 2001;166:3672-7.
25. Schuler G, Steinman RM. Murine epidermal Langerhans cells mature into potent immunostimulatory dendritic cells in vitro. J Exp Med 1985;161:526-46.
26. Heufler C, Koch F, Schuler G. Granulocyte/macrophage colony-stimulating factor and interleukin 1 mediate the maturation of murine epidermal Langerhans cells into potent immunostimulatory dendritic cells. J Exp Med 1988;167:700-5.
27. Cumberbatch M, Dearman RJ, Kimber I. Langerhans cells require signals from both tumour necrosis factor α and interleukin 1β for migration. Immunology 1997;92:388-95.
28. Cumberbatch M, Bhushan M, Dearman RJ, et al. IL-1β-induced Langerhans' cell migration and TNF-α production in human skin: regulation by lactoferrin. Clin Exp Immunol 2003;132:352-9.
29. Wang B, Zhuang L, Fujisawa H, et al. Enhanced epidermal Langerhans cell migration in IL-10 knockout mice. J Immunol 1999;162:277-83.
30. Kondo S, Mackenzie RC, Sauder DN. Interleukin-10 inhibits the elicitation phase of allergic contact sensitivity. J Invest Dermatol 1994;103:811-4.
31. Muller G, Knop J, Enk AH. Is cytokine expression responsible for differences between allergens and irritants? Am J Contact Dermat 1996;7:177-84.
32. Kligman AM. The identification of contact allergens by human assay. II. Factors influencing the induction and measurement of allergic contact dermatitis. J Invest Dermatol 1966;47:375-92.
33. Smith HR, Holloway D, Armstrong DK, et al. Irritant thresholds in subjects with colophony allergy. Contact Dermatitis 2000;42:95-7.
34. Cumberbatch M, Scott RC, Basketter DA, et al. Influence of sodium lauryl sulphate on 2,4-dinitrochlorobenzene-induced lymph node activation. Toxicology 1993;77:181-91.
35. Dearman RJ, Cumberbatch M, Hilton J, et al. Influence of dibutyl phthalate on dermal sensitization to fluorescein isothiocyanate. Fundam Appl Toxicol 1996;33:24-30.
36. Heylings JR, Clowes HM, Cumberbatch M, et al. Sensitization to 2,4-dinitrochlorobenzene: influence of vehicle on absorption and lymph node activation. Toxicology 1996;109:57-65.
37. Basketter DA, Gerberick GF, Kimber I. Skin sensitisation, vehicle effects and the local lymph node assay. Food Chem Toxicol 2001;39:621-7.
38. Warbrick EV, Dearman RJ, Basketter DA, et al. Influence of application vehicle on skin sensitization to methylchlorothiazolinone/isothiazolinone: an analysis using the local lymph node assay. Contact Dermatitis 1999;41:325-9.
39. Wright ZM, Basketter DA, Blaikie L, et al. Vehicle effects on the skin sensitizing potency of four chemicals: assessment using the local lymph node assay. Int J Cosmet Sci 2001;23:75-83.
40. Weltzien HU, Moulon C, Martin S, et al. T cell immune responses to haptens. Structural models for allergic and autoimmune reactions. Toxicology 1996;107:141-51.
41. Lu L, Vollmer J, Moulon C, et al. Components of the ligand for a Ni++ reactive human T cell clone. J Exp Med 2003;197:567-74.
42. Rennert PD, Hochmann PS, Flavell RA, et al. Essential role of lymph nodes in contact hypersensitivity revealed in lymphotoxin-α-deficient mice. J Exp Med 2001;193:1227-38.
43. Kimber I, Kinnaird A, Peters SW, et al. Correlation between lymphocyte proliferative responses and dendritic cell migration in regional lymph nodes following skin painting with contact-sensitizing agents. Int Arch Allergy Appl Immunol 1990;93:47-53.
44. Kimber I, Dearman RJ. Investigation of lymph node cell proliferation as a possible immunological correlate of contact sensitising potential. Food Chem Toxicol 1991;29:125-9.
45. Kimber I, Dearman RJ. Allergic contact dermatitis: the cellular effectors. Contact Dermatitis 2002;46:1-5.
46. Basketter DA, Blaikie L, Dearman RJ, et al. Use of the local lymph node assay for the estimation of relative contact allergenic potency. Contact Dermatitis 2000;42:344-8.
47. Gerberick GF, Robinson MK, Ryan CA, et al. Contact allergenic potency: correlation of human and local lymph node assay data. Am J Contact Dermatitis 2001;12:156-61.
48. Mosmann TR, Sad S. The expanding universe of T cell subsets: Th1, Th2 and more. Immunol Today 1996;17:138-46.
49. Kimber I, Dearman RJ. Cell and molecular biology of chemical allergy. Clin Rev Allergy Immunol 1997;15:145-68.
50. Xu H, Dilulio NA, Fairchild RL. T cell populations primed by hapten sensitization in contact sensitivity are distinguished by polarized patterns of cytokine production. Interferon-γ-producing (Tc1) effector CD8+ T cells and interleukin (IL)-4/IL-10 producing (Th2) negative regulatory CD4+ T cells. J Exp Med 1996;183:1001-12.
51. Dearman RJ, Basketter DA, Kimber I. Differential cytokine production following chronic exposure of mice to chemical respiratory and contact allergens. Immunology 1995;86:545-50.
52. Dearman RJ, Warbrick EV, Skinner R, et al. Cytokine fingerprinting of chemical allergens: species considerations and statistical analyses. Food Chem Toxicol 2002;40:1881-92.
53. Dearman RJ, Betts CJ, Humphreys N, et al. Chemical allergy: considerations for the practical application of cytokine fingerprinting. Toxicol Sci 2003;71:137-45.
54. H2 responses which can downregulate the elicitation of murine contact hypersensitivity. Clin Exp Allergy 1999;29:271-9.
55. Kitagaki H, Ono N, Hayakawa K, et al. Repeated elicitation of contact hypersensitivity induces a shift in cutaneous cytokine mileau from a T helper cell type 1 to a T helper cell type 2 profile. J Immunol 1997;159:2484-91.
56. Kitagaki H, Kimishima M, Teraki Y, et al. Distinct in vivo and in vitro cytokine profiles of draining lymph node cells in acute and chronic phases of contact hypersensitivity: importance of a type 2 cytokine-rich cutaneous milieu for the development of an early-type response in the chronic phase. J Immunol 1999;163:1265-73.
57. Fleming CJ, Burden AD, Forsyth A. The genetics of allergic contact hypersensitivity to nickel. Contact Dermatitis 1999;41:251-3.
58. Schnuch A, Westphal GA, Muller MM, et al. Genotype and phenotype of N-acetyltransferase 2 (NAT2) polymorphism in patients with contact allergy. Contact Dermatitis 1998;38:209-11.
59. Emtestam L, Zetterquist H, Olerup O. HLA-DR, -DQ and -DP alleles in nickel, chromium, and/or cobalt-sensitive individuals: genomic analysis based on restriction fragment length polymorphisms. J Invest Dermatol 1993;100:271-4.
60. Menne T, Holm NV. Hand eczema in nickel-sensitive female twins. Genetic predisposition and environmental factors. Contact Dermatitis 1983;9:289-96.
61. Desvignes C, Etchart N, Kehren J, et al. Oral administration of hapten inhibits in vivo induction of specific cytotoxic CD8+ T cells mediating tissue inflammation: a role for regulatory CD4+ T cells. J Immunol 2000;164:2515-22.
62. van Hoogstraten IM, Boden D, von Blomberg ME, et al. Persistent immune tolerance to nickel and chromium by oral administration prior to cutaneous sensitization. J Invest Dermatol 1992;99:608-16.
63. van Hoogstraten IM, von Blomberg BM, Boden D, et al. Non-sensitizing epicutaneous skin tests prevent subsequent induction of immune tolerance. J Invest Dermatol 1994;102:80-3.
64. van Hoogstraten IM, Andersen KE, von Blomberg BM, et al. Reduced frequency of nickel allergy upon oral nickel contact at an early age. Clin Exp Immunol 1991;85:441-5.